No. 3 (52) (2023)

View No. 3 (52) (2023)

Published: 2023-08-22

Full Issue

PDF (Русский)

Key Article

Clinical guidelines for lipid disorders 2023. What's new?

M. V. Ezhov, I. V. Sergienko, V. V. Kukharchuk

5-9
- PDF (Русский)

Review

The role of mitochondrial dysfunction in the pathogenesis of inflammatory diseases

T. V. Tolstik, T. V. Kirichenko, A. I. Bogatyreva, Yu. V. Markina, A. M. Markin, S. G. Kozlov

10-17
- PDF (Русский)
Statin-associated myopathies: possible risks and potential of pharmacogenetic approach for their prevention

А. А. Nekrasov, L. A. Lugovaya, T. A. Nekrasova, Е. S. Timoshchenko

18-27
- PDF (Русский)

Original research paper

The prevalence of severe hypercholesterolemia and lipid-lowering therapy in patients with sensitive coronary syndrome and ischemic cerebral stroke in the regional vascular center in Chita

D. N. Zaytsev, I. V. Slobodskaya, P. V. Vasilenko

28-36
- PDF (Русский)
The hybrid surgery concepts for atherosclerotic lesions of lower limb arteries

A. A. Kuchay, A. N. Lipin, P. S. Kurianov, N. N. Gruzdev, K. A. Atmatzas , N. R. Karelina, L. Yu. Artyukh

37-43
- PDF (Русский)
Parameters of arterial stiffness as non-invasive markers of coronary heart disease in young people

V. E. Oleinikov, A. A. Khromova, L. I. Salyamova, K. N. Polezhaeva, Yu. A. Tomashevskaya

44-52
- PDF (Русский)

Clinical Case

Clinical manifestations and efficacy of lipid-lowering therapy in a double heterozygous patient with familial hypercholesterolemia

A.N. Meshkov, V. I. Mikhailina, S.A. Smetnev, A. V. Kiseleva, E. A. Sotnikova, O. M. Drapkina

53-58
- PDF (Русский)